Related Experiment Videos
Intracellular signalling pathways regulating initiation factor eIF4E phosphorylation during the activation of cell
1Department of Biochemistry, School of Biological Sciences, University of Sussex, Brighton, U.K.
Biochemical Society Transactions
|May 1, 1997
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
An efficient and cost-effective method of generating postnatal (P2-5) mouse primary hippocampal neuronal cultures.
Journal of neuroscience methods·2017
Psychological approaches to chronic pain management: evidence and challenges.
British journal of anaesthesia·2013
Initiation factor modifications in the preapoptotic phase.
Cell death and differentiation·2005
Behavioural treatment for chronic low-back pain.
The Cochrane database of systematic reviews·2005
Molecular mechanisms of Kir channel gating.
Biochemical Society transactions·2026
Communication is key: combinatorial phosphorylation and functional cross-talk in the RNA polymerase II CTD code.
Biochemical Society transactions·2026
The tumor microenvironment in pancreatic cancer: from composition to therapeutic targeting.
Biochemical Society transactions·2026
Deciphering influenza B virus-derived peptides and their presentation by HLA class I molecules.
Biochemical Society transactions·2026
Temperature regulation of cell cycle and growth dynamics in Arabidopsis.
Biochemical Society transactions·2026
Evolution of self-reactive B cells: lessons from a lupus model.
Biochemical Society transactions·2026
Development of cecal volvulus after redo pancreas transplantation.
Journal of surgical case reports·2026
Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.
Iranian journal of otorhinolaryngology·2026
Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.
Research and practice in thrombosis and haemostasis·2026